Systolic blood pressure, cardiovascular outcomes and efficacy and safety of sacubitril/valsartan (LCZ696) in patients with chronic heart failure and reduced ejection fraction: results from PARADIGM-HF-Reference-Cited by-同舟云学术

Systolic blood pressure, cardiovascular outcomes and efficacy and safety of sacubitril/valsartan (LCZ696) in patients with chronic heart failure and reduced ejection fraction: results from PARADIGM-HF

Published:2017-02-01 Issue:15 Volume:38 Page:1132-1143
ISSN:0195-668X
Container-title:European Heart Journal
language:en
Short-container-title:

Author:

Böhm Michael,Young Robin,Jhund Pardeep S.,Solomon Scott D.,Gong Jianjian,Lefkowitz Martin P.,Rizkala Adel R.,Rouleau Jean L.,Shi Victor C.,Swedberg Karl,Zile Michael R.,Packer Milton,McMurray John J.V.

Publisher

Oxford University Press (OUP)

Subject

Cardiology and Cardiovascular Medicine

Link

http://academic.oup.com/eurheartj/article-pdf/38/15/1132/14060342/ehw570.pdf

Reference15 articles.

1. Clinical profile and prognostic value of low systolic blood pressure in patients hospitalized for heart failure with reduced ejection fraction: insights from the Efficacy of Vasopressin Antagonism in Heart Failure: Outcome Study with Tolvaptan (EVEREST) trial;Am Heart J,2013

2. Current management and future directions for the treatment of patients hospitalized for heart failure with low blood pressure;Heart Fail Rev,2013

3. Efficacy and safety of ivabradine in patients with chronic systolic heart failure according to blood pressure level in SHIFT;SHIFT Investigators;Eur J Heart Fail,2014

4. Dual angiotensin receptor and neprilysin inhibition as an alternative to angiotensin-converting enzyme inhibition in patients with chronic systolic heart failure: rationale for and design of the Prospective comparison of ARNI with ACEI to Determine Impact on Global Mortality and morbidity in Heart Failure trial (PARADIGM-HF);PARADIGM-HF Committees and Investigators;Eur J Heart Fail,2013

5. Angiotensin-neprilysin inhibition versus enalapril in heart failure;PARADIGM-HF Investigators and Committees;N Engl J Med,2014

Cited by 174 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Vericiguat in heart failure with reduced ejection fraction patients on guideline-directed medical therapy: Insights from a 6-month real-world study;International Journal of Cardiology;2024-12

2. Association Between Systolic Blood Pressure and in-Hospital Mortality Among Congestive Heart Failure Patients with Chronic Obstructive Pulmonary Disease in the Intensive Care Unit: A Retrospective Cohort Study;International Journal of Chronic Obstructive Pulmonary Disease;2024-09

3. Incidence and risk factors of hypotension-related adverse events among Japanese patients with heart failure receiving sacubitril/valsartan or enalapril: Results from the PARALLEL-HF study;Journal of Cardiology;2024-09

4. 2024 Update to the 2020 ACC/AHA Clinical Performance and Quality Measures for Adults With Heart Failure;Journal of the American College of Cardiology;2024-09

5. 2024 ACC Expert Consensus Decision Pathway on Clinical Assessment, Management, and Trajectory of Patients Hospitalized With Heart Failure Focused Update;Journal of the American College of Cardiology;2024-08